-
Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Ovarian Cancer - 3/19/2022
1:30:54
-
Year in Review: Kidney and Bladder Cancer - 3/8/2022
1:04:17
-
The Great Adjuvant Debate — Exploring the Role of Novel Therapies in the Management of Localized Cancer - 2/28/2022
1:04:38
-
Key Considerations in the Optimal Clinical Care of Patients with Small Cell Lung Cancer - 2/9/2022
1:04:00
-
Exploring the Current and Future Role of B-Cell Maturation Antigen-Directed Therapy in the Management of Multiple Myeloma - 2/7/2022
1:01:03
-
Exploring the Current and Changing Paradigm for the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma - 2/2/2022
1:15:33
-
Year in Review: Gastric, Gastroesophageal Junction and Esophageal Cancer - 2/1/2022
1:01:50
-
Year in Review: Acute Myeloid Leukemia and Myelodysplastic Syndromes - 1/27/2022
1:01:02
-
Year in Review – Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology: Chronic Lymphocytic Leukemia - 1/25/2022
59:55
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology-Immunotherapy and Other Nontargeted Approaches for Lung Cancer - 1/13/2022
1:02:48
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology-Targeted Therapy for Non-Small Cell Lung Cancer - 1/11/2022
1:02:13
- Next Page
